Diario Médico & Correo Farmacéutico

What Diario Médico & Correo Farmacéutico does

Diario Médico & Correo Farmacéutico is the professional healthcare publishing arm of Unidad Editorial's Health Area in Spain, operating two flagship digital publications: Diario Médico, founded in 1992, and Correo Farmacéutico, launched in 1999. The publications serve verified healthcare professionals — physicians across more than 30 specialties, pharmacists, nurses, and ancillary professionals such as psychologists, dentists, and veterinarians — providing daily news, policy analysis, clinical research coverage, and opinion content through a digital-first publishing platform. The platform requires professional credential registration for access to gated content and supports targeted newsletter subscriptions across streams such as Farmacia, Enfermería, Empresas, and daily news alerts. The company holds S.V.P. nº 01/20-W-CM authorization from the Comunidad de Madrid, restricting the platform to professionals authorized to prescribe or dispense medications, and operates under GDPR-compliant data practices.

The underlying technology is a specialized content management and publishing platform with newsletter delivery infrastructure, professional registration and credential verification, and cross-publication integration within the Unidad Editorial media ecosystem (which includes El Mundo, Expansión, and Marca). The product portfolio also includes CuídatePlus, a consumer-facing health education sub-brand. The business model is not publicly disclosed but appears to be a mix of advertising (branded content from pharmaceutical sponsors such as Novo Nordisk, Galderma, Lilly, and AESEG is visible), events, and registration-gated premium access. The legal entity is Unidad Editorial Revistas, S.L.U., a wholly-owned subsidiary of Unidad Editorial, S.A., which is in turn controlled by RCS MediaGroup SpA, a publicly traded Italian media conglomerate. The company operates with a lean team of 15 employees from its headquarters in Madrid, reflecting the asset-light, editorial-centric nature of the business.

Name

Diario Médico & Correo Farmacéutico

Legal name

Unidad Editorial Revistas, S.L.U.

Website

https://diariomedico.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Diario Médico & Correo Farmacéutico is a Spanish digital publishing platform of Unidad Editorial that delivers verified-credential healthcare news, policy analysis, and specialty content to physicians, pharmacists, and nurses across more than 30 medical specialties.

Ownership category

akta.pro rank

Product category

Healthcare Professional Publishing

NAICS

Periodical Publishers (513120)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Business, Financial & Trade News Publishers (MPAJADAC)

akta.pro secondary industry

Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)

Keywords

• Medical journalism
• Pharmaceutical news
• Healthcare professional media
• Specialty medical content
• Clinical news publishing

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels3 records

Marketing channels4 records

Core offering

Diario Médico and Correo Farmacéutico publish digital professional news, opinion, and analysis content targeting Spanish healthcare professionals across medicine, pharmacy, and nursing specialties. The publications deliver daily healthcare news, policy coverage, clinical research updates, regulatory analysis, and editorial commentary through a digital platform with professional registration and newsletter distribution.

Product overview

Diario Médico and Correo Farmacéutico are the flagship professional reference publications of the Health Area of Unidad Editorial, a leading Spanish media group. The portfolio consists of two main digital publications—Diario Médico for medical professionals and Correo Farmacéutico for pharmaceutical professionals—alongside CuídatePlus for general health education. Both core publications offer news, opinion, research coverage, and policy analysis through a digital platform with registered professional user accounts, newsletter subscriptions, and specialized content sections organized by medical specialty and professional category.

Differentiator

Problem solved

Functional benefit

Brands

• CuídatePlus: Web-based prevention and health education platform directed at the general public.

Products and services

• Diario Médico Digital publication and news portal providing professional medical news, research updates, policy coverage, and opinion pieces for physicians and medical professionals across 30+ specialties in Spain.
• Correo Farmacéutico Digital publication and news portal focused on pharmaceutical industry news, pharmacy practice, medication policies, dispensing guidance, and professional development for pharmacists.
• CuídatePlus Health prevention and education website directed at the general public, part of the Unidad Editorial Health Area portfolio, providing consumer-facing health information.
• Newsletter Subscription Services Email newsletter subscriptions covering topics such as Farmacia, Enfermería, Empresas, and daily news alerts for registered professional users in the healthcare sector.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• CuídatePluscoreOthersCuídatePlus is the web-based prevention and health education platform directed at the general public, part of the Health Area of Unidad Editorial alongside Diario Médico and Correo Farmacéutico

Recent moves5 records

Expansion highlights4 records

Direct peers

• El Global: Spanish pharmaceutical industry publication covering pharma professionals and the medication supply chain. Direct peer to Correo Farmacéutico in the Spanish pharmacy trade-press segment.
• Gaceta Médica: Spanish healthcare publication focused on medical professionals and the pharmaceutical industry. Competitor in the trade-health news category with similar B2B pharma advertising model.
• Redacción Médica: Leading Spanish professional medical news publication serving physicians and healthcare professionals. Closest direct competitor to Diario Médico in Spain, with similar editorial coverage of healthcare policy, clinical news, and professional development.
• Sanifax: Spanish pharmacy and pharmaceutical industry news service. Direct competitor to Correo Farmacéutico for community pharmacist audience and pharmaceutical industry advertising.
• IM Médico: Spanish medical-professional publication targeting hospital and specialty physicians. Comparable audience (specialist doctors) and competing ad inventory for pharma marketing spend in Spain.
• Acta Sanitaria: Spanish digital health news outlet covering medical, nursing, and pharmaceutical professionals. Direct competitor in the same Spanish healthcare-professional news category with overlapping audience segments.

Broad incumbents

• Medscape: Global, English-language professional medical news and clinical reference platform. While not Spanish-language, it competes directly for the time and attention of Spanish healthcare professionals and is referenced as a free alternative.
• Unidad Editorial (El Mundo / Marca): Parent media group operating El Mundo and Marca. Comparable as the broader publishing conglomerate that owns Diario Médico and Correo Farmacéutico, with cross-promotion and shared advertising infrastructure.
• JAMA Network: Medical journal publishing network providing clinical research, news, and CME for physicians. Comparable as a physician-targeted editorial brand competing for the same professional audience's attention and CME/compliance engagement.

Others

• CuídatePlus (sister brand): Consumer-facing health education platform owned by the same parent (Unidad Editorial). Compares as a peer because it shares editorial infrastructure and demonstrates the group's consumer-health expansion strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/DiarioMedico
• LinkedInlinkedin.com/company/diario-m%C3%A9dico-y-correo-farmac%C3%A9utico

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diario Médico & Correo Farmacéutico